Banco Bilbao Vizcaya Argentaria S.A. Purchases 6,023 Shares of Colgate-Palmolive Company $CL

Banco Bilbao Vizcaya Argentaria S.A. increased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 3.3% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 189,894 shares of the company’s stock after acquiring an additional 6,023 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Colgate-Palmolive were worth $15,180,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. S.A. Mason LLC increased its holdings in shares of Colgate-Palmolive by 3.9% in the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock worth $280,000 after acquiring an additional 130 shares in the last quarter. Security National Bank of Sioux City Iowa IA lifted its holdings in shares of Colgate-Palmolive by 0.8% during the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock valued at $1,298,000 after purchasing an additional 130 shares in the last quarter. Stratos Wealth Advisors LLC grew its position in shares of Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after purchasing an additional 130 shares during the period. Cordatus Wealth Management LLC grew its position in shares of Colgate-Palmolive by 0.6% in the 2nd quarter. Cordatus Wealth Management LLC now owns 23,036 shares of the company’s stock valued at $2,094,000 after purchasing an additional 134 shares during the period. Finally, Chicago Partners Investment Group LLC increased its stake in Colgate-Palmolive by 1.5% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company’s stock worth $724,000 after purchasing an additional 136 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In related news, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the sale, the insider owned 17,645 shares in the company, valued at approximately $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Sally Massey sold 15,851 shares of the stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 184,683 shares of company stock valued at $17,486,693. Corporate insiders own 0.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of several research analyst reports. Barclays lifted their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Bank of America increased their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Citigroup upped their target price on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 target price on shares of Colgate-Palmolive in a report on Friday, February 20th. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Colgate-Palmolive Price Performance

Shares of CL opened at $88.85 on Monday. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The stock has a market capitalization of $71.62 billion, a P/E ratio of 33.91, a P/E/G ratio of 3.98 and a beta of 0.28. The company has a 50 day moving average of $90.11 and a 200-day moving average of $83.22.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the previous year, the firm posted $0.91 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s payout ratio is presently 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.